3.0-T心血管磁共振检测出血性心肌梗死:空间表现、时间依赖性与最佳采集方案的深入见解
本研究在20只再灌注心肌梗死犬模型及50例再灌注ST段抬高型心肌梗死患者中,探讨3.0-T CMR检测出血性心肌梗死(hMI)的信号特征与时间依赖性。结果显示再灌注后1小时内T1、T2、T2*均不能可靠检测hMI;T2*在24小时至7天可检测hMI且体积与透壁性稳定;T2 mapping在5至7天诊断hMI的AUC为0.98(敏感度与特异度≥0.95),而T1在所有时间点敏感度<0.8。
要点
- 再灌注后24小时至7天,T2* mapping可检测出血性心肌梗死,T2*值从基线27.0±2.4 ms降至11.7±2.8 ms(P<0.001)。
- 再灌注后5至7天,T2 mapping诊断hMI的AUC为0.98,敏感度与特异度均≥0.95(以T2*为参照)。
- 再灌注后1小时内,T1、T2、T2*均不能可靠检测hMI;T1在所有时间点敏感度<0.8。
核心结论
- 再灌注后即刻T1、T2、T2*均不能可靠检测hMI;T2*可在再灌注后24小时至7天诊断hMI;若CMR在再灌注后5至7天进行,T2 mapping是T2*的有力替代;T1诊断hMI的挑战显著大于T2*和T2。
研究设计与样本
- 研究采用20只犬再灌注MI模型,在基线及再灌注后第一周多个时间点行3.0-T CMR,分析T1、T2、T2* mapping在hMI、非hMI及远程区域的时间依赖性关系;另纳入50例再灌注ST段抬高型心肌梗死患者评估临床可行性。
关键影像表现/征象
- 组织病理学显示再灌注后1小时内即出现hMI,但T1、T2、T2* CMR均不能可靠检测。
- 再灌注后24小时至7天,T2* mapping可检测hMI,且hMI体积与透壁性保持稳定。
- 再灌注后5至7天,T2 mapping上hMI显示最清晰。
- T1 mapping在所有时间点检测hMI的敏感度均<0.8。
诊断标准与关键数值
- 以T2*为参照,再灌注后5至7天T2 mapping诊断hMI的AUC为0.98,敏感度与特异度均≥0.95。
- T2* mapping检测hMI:hMI区域T2*值为11.7±2.8 ms,基线为27.0±2.4 ms(P<0.001)。
- T1 mapping检测hMI在所有时间点敏感度<0.8。
临床应用与阅片要点
- 再灌注后24小时至7天可行T2* mapping诊断hMI。
- 若CMR在再灌注后5至7天进行,T2 mapping可作为T2* mapping诊断hMI的替代方案。
- 再灌注后即刻不采用T1、T2或T2* CMR检测hMI。
- T1 mapping在3.0-T诊断hMI的挑战显著大于T2*和T2。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhagic myocardial infarction (hMI) can rapidly diminish the benefits of reperfusion therapy and direct the heart toward chronic heart failure. T2∗ cardiac magnetic resonance (CMR) is the reference standard for detecting hMI. However, the lack of clarity around the earliest time point for detection, time-dependent changes in hemorrhage volume, and the optimal methods for detection can limit the development of strategies to manage hMI.
OBJECTIVES: The authors investigated CMR signal characteristics of hMI through time-lapse multiparametric mapping using a clinically relevant animal model and evaluated the translatability in ST-segment elevation MI patients when possible.
METHODS: Canines (N = 20) underwent 3.0-T CMR at baseline and various time points over the first week of reperfused MI. Time-dependent relationships between T1, T2, and T2∗ mapping of hMI, non-hMI, and remote territories were determined. Reperfused ST-segment elevation MI patients (N = 50) were studied to establish clinically feasibility.
RESULTS: Although hMI was evident <1 hour after reperfusion on histopathology, it was not reliably detected with T1, T2, or T2∗ CMR. However, 24 hours to 7 days postreperfusion, hMI was detectable on T2∗ (27.0 ± 2.4 ms [baseline] vs 11.7 ± 2.8 ms [hMI]; P < 0.001), with stable volume and transmurality. In T2 maps, hMI was most visible 5 to 7 days postreperfusion with an area under the curve of 0.98 (sensitivity and specificity ≥0.95) relative to T2∗. However, this was not the case with T1 (sensitivity <0.8, across all time points).
CONCLUSIONS: HMI cannot be reliably detected with T1, T2, or T2∗ on 3.0-T CMR immediately after reperfusion. However, T2∗ CMR can be used to diagnose hMI between 24 hours and 7 days postreperfusion. T2 maps at 3.0-T are a strong alternative to T2∗ maps for diagnosing hMI, provided CMR is performed 5 to 7 days postreperfusion. However, diagnosing hMI with T1 is significantly more challenging at 3.0-T compared with both T2∗ and T2.
引用
- Chen Y, Jin H, Guan X, et al. Detecting Hemorrhagic Myocardial Infarction With 3.0-T CMR: Insights Into Spatial Manifestation, Time-Dependence, and Optimal Acquisitions. JACC Cardiovasc Imaging. 2025. PMID: 39797882. doi:10.1016/j.jcmg.2024.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。